These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28461331)

  • 1. Sirtuin 2 mutations in human cancers impair its function in genome maintenance.
    Head PE; Zhang H; Bastien AJ; Koyen AE; Withers AE; Daddacha WB; Cheng X; Yu DS
    J Biol Chem; 2017 Jun; 292(24):9919-9931. PubMed ID: 28461331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.
    Zhang H; Head PE; Daddacha W; Park SH; Li X; Pan Y; Madden MZ; Duong DM; Xie M; Yu B; Warren MD; Liu EA; Dhere VR; Li C; Pradilla I; Torres MA; Wang Y; Dynan WS; Doetsch PW; Deng X; Seyfried NT; Gius D; Yu DS
    Cell Rep; 2016 Feb; 14(6):1435-1447. PubMed ID: 26854234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT2 directs the replication stress response through CDK9 deacetylation.
    Zhang H; Park SH; Pantazides BG; Karpiuk O; Warren MD; Hardy CW; Duong DM; Park SJ; Kim HS; Vassilopoulos A; Seyfried NT; Johnsen SA; Gius D; Yu DS
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13546-51. PubMed ID: 23898190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
    Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
    J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.
    Kim HS; Vassilopoulos A; Wang RH; Lahusen T; Xiao Z; Xu X; Li C; Veenstra TD; Li B; Yu H; Ji J; Wang XW; Park SH; Cha YI; Gius D; Deng CX
    Cancer Cell; 2011 Oct; 20(4):487-99. PubMed ID: 22014574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.
    Serrano L; Martínez-Redondo P; Marazuela-Duque A; Vazquez BN; Dooley SJ; Voigt P; Beck DB; Kane-Goldsmith N; Tong Q; Rabanal RM; Fondevila D; Muñoz P; Krüger M; Tischfield JA; Vaquero A
    Genes Dev; 2013 Mar; 27(6):639-53. PubMed ID: 23468428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol inhibits SIRT2 deacetylase through a conformation-specific, allosteric site.
    Weiser BP; Eckenhoff RG
    J Biol Chem; 2015 Mar; 290(13):8559-68. PubMed ID: 25666612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.
    Sakkiah S; Chandrasekaran M; Lee Y; Kim S; Lee KW
    J Biomol Struct Dyn; 2012; 30(3):235-54. PubMed ID: 22694102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.
    Bi D; Yang J; Hong JY; Parikh P; Hinds N; Infanti J; Lin H; Weiser BP
    Biochemistry; 2020 Oct; 59(40):3869-3878. PubMed ID: 32941003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90.
    Min JS; Kim JC; Kim JA; Kang I; Ahn JK
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1230-1238. PubMed ID: 29908203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
    Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
    PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
    Yu J; Wu Y; Yang P
    J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifaceted regulation of sirtuin 2 (Sirt2) deacetylase activity.
    Abeywardana MY; Whedon SD; Lee K; Nam E; Dovarganes R; DuBois-Coyne S; Haque IA; Wang ZA; Cole PA
    J Biol Chem; 2024 Sep; 300(9):107722. PubMed ID: 39214297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).
    Ji S; Doucette JR; Nazarali AJ
    Methods Mol Biol; 2016; 1436():189-99. PubMed ID: 27246216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT2 promotes base excision repair by transcriptionally activating OGG1 in an ATM/ATR-dependent manner.
    Geng A; Sun J; Tang H; Yu Y; Wang X; Zhang J; Wang X; Sun X; Zhou X; Gao N; Tan R; Xu Z; Jiang Y; Mao Z
    Nucleic Acids Res; 2024 May; 52(9):5107-5120. PubMed ID: 38554113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.
    Liu G; Park SH; Imbesi M; Nathan WJ; Zou X; Zhu Y; Jiang H; Parisiadou L; Gius D
    Antioxid Redox Signal; 2017 May; 26(15):849-863. PubMed ID: 27460777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomic analysis of the lysine acetylome reveals diverse SIRT2 substrates.
    Zhang H; Dammer EB; Duong DM; Danelia D; Seyfried NT; Yu DS
    Sci Rep; 2022 Mar; 12(1):3822. PubMed ID: 35264593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
    Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.
    Rumpf T; Schiedel M; Karaman B; Roessler C; North BJ; Lehotzky A; Oláh J; Ladwein KI; Schmidtkunz K; Gajer M; Pannek M; Steegborn C; Sinclair DA; Gerhardt S; Ovádi J; Schutkowski M; Sippl W; Einsle O; Jung M
    Nat Commun; 2015 Feb; 6():6263. PubMed ID: 25672491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.
    Jiang C; Liu J; Guo M; Gao X; Wu X; Bai N; Guo W; Li N; Yi F; Cheng R; Xu H; Zhou T; Jiang B; Sun T; Wei S; Cao L
    Int J Biol Sci; 2020; 16(15):3075-3084. PubMed ID: 33061819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.